COLLPLANT HLDGS Stock Price (NASDAQ:CLGN)

Add to My Stocks
$5.15 $0.05 (0.98%) CLGN stock closing price Sep 18, 2018 (Closing)
Prev Close* : $5.1
Market Cap:
$17.46M
Day Low: $5.15
52 Week Low: $4.70
Open: $5.17
Volume: -
Day High: $5.18
52 Week High: $8.99
Dividend:
0.00

Latest Stock Market News

Latest Articles

CLGN Stockcharts

View CLGN PE ratio, PS ratio stocks charts and compare with peers.
CLGN Chart
Note: Compare COLLPLANT HLDGS stock price history with the index and industry peers.

COLLPLANT HLDGS Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
27.44
PB ratio (
price to book ratio
)
-999.0000

COLLPLANT HLDGS Returns

ROE
(return on equity)
-27%

COLLPLANT HLDGS Financial Ratios

Asset Turnover
0.12
Receivables Turnover
-
Debt to Equity
0
Dividend Yield
0%

CLGN Industry Peers

Company Price Change (%)
Egalet (EGLT)0.330.01 (2.94%)
Bioasis Technologies (BIOAF)0.310.01 (3.13%)
Essa Pharma (EPIX)3.070.2 (6.12%)
Eyegate Pharma (EYEG)0.350.02 (5.41%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ChemoCentryx (CCXI)11.521.03 (9.82%)
AcelRx Pharma (ACRX)3.750.3 (8.7%)
MELINTA THERAPT (MLNT)4.450.35 (8.54%)
Galectin Therapeutics (GALT)6.020.28 (4.88%)
GlycoMimetics (GLYC)14.580.67 (4.82%)
Achaogen (AKAO)4.280.17 (4.14%)
Concert Pharma (CNCE)13.420.51 (3.95%)
Top gainers from Medical-Drugs industry
* As of Sep 19, 2018
CompanyPriceChange (%)
MADRIGAL PHARMA (MDGL)207.321.13 (9.25%)
Tetraphase Pharmaceuticals (TTPH)2.90.16 (5.23%)
Recro Pharma (REPH)7.410.29 (3.77%)
Corcept Therapeutics (CORT)14.260.48 (3.26%)
Lannett Co (LCI)4.750.15 (3.06%)
Catalyst Pharma (CPRX)3.10.09 (2.82%)
Galmed Pharma (GLMD)12.610.24 (1.87%)
Top losers from Medical-Drugs industry
* As of Sep 19, 2018

COLLPLANT HLDGS Financial Statements

income statement20172016
Net Sales or Revenues--
Net Income-6.02M-7.9M
Total Operating Expense6.44M7.88M
View COLLPLANT HLDGS income statement
balance sheet20172016
Total Assets8.08M4.09M
Total Liabilities5.46M2.62M
Shareholders Equity2.62M1.46M
View COLLPLANT HLDGS balance sheet
cash flow statement20172016
Net Increase (Decrease) in Assets Liabilities-0.89M1.11M
Net Cash from (used by) Operating Activities-5.15M-5.48M
Increase (Decrease) in Prop Plant And Equipment-0.12M-0.13M
View COLLPLANT HLDGS cash flow statement

COLLPLANT HLDGS Stock Message Board